Research Article
Use of PEGylated Recombinant Human Growth Hormone in Chinese Children with Growth Hormone Deficiency: A 24-Month Follow-Up Study
Table 2
Treatment-related adverse events reported in each group.
| | PEGylated rhGH group (n = 49) | Daily rhGH group (n = 49) | | N (%) | N (%) |
| Hypothyroidism | 2 (4.1%) | 3 (6.1%) | | Peripheral edema | 0 | 0 | | Headache | 0 | 0 | | Injection-site lipoatrophy | 0 | 0 | | Diabetes mellitus | 0 | 0 | |
|
|